Riskpilot← Back to searchSign inGet full accessEhrnebo Development AB
ABActiveOrg 5565367553Valhalls Väg 15Activities of holding companies · NACE 6421Est. 19960 employees
Revenue 2025
SEK 264K
+4% vs 2024
EBITDA margin
408.6%
+158% vs 2024
Equity ratio
56.5%
Financial strength
Net profit 2025
SEK 4,9M
+311% vs 2024
| Revenue | SEK 264K | +4% |
| EBITDA | SEK 1,1M | +158% |
| Net profit | SEK 4,9M | +311% |
| Total assets | SEK 64,8M | +4% |
| Equity | SEK 36,6M | +16% |
| Employees | 0 | — |
Legal name
Ehrnebo Development AB
Org number
5565367553
Legal form
Aktiebolag
NACE code
6421 · Activities of holding companies
Founded
17 december 1996
Share capital
SEK 250 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva konsultverksamhet inom läkemedelsområdet och medicinskt-tekniska området vid ansökan om marknadsföringstillstånd och kliniska prövningar samt därtill angränsande områden, bedriva konsultverksamhet och försäljning inom allmän data- behandling (ADB) samt bedriva handel med och förvaltning av fast egendom och värdehandlingar ävensom idka därmed förenlig verksamhet.
Address
Valhalls Väg 15
Phone
+4618713200
Email
mats.ehrnebo@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 0 | 0 | 0 | 63 | 117 | 314 | 253 | 264 |
| Staff expenses | — | — | — | — | — | — | — | — | — | 1 152 |
| EBITDA | −2 541 | −242 | 2 521 | −447 | 1 159 | −791 | −9 674 | −13 349 | −1 845 | 1 077 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | — |
| EBIT | −2 541 | −242 | 2 521 | −447 | 1 159 | −791 | −9 674 | −13 349 | −1 845 | 1 077 |
| Net financials | 1 367 | −1 711 | 1 343 | 1 980 | 528 | 746 | 38 316 | 2 819 | −6 078 | 2 719 |
| Profit before tax | 375 | 871 | 6 857 | 6 009 | 5 403 | 1 382 | 31 178 | −10 531 | −2 264 | 5 215 |
| Tax | −364 | −854 | −801 | −937 | −758 | −117 | −2 | −88 | −75 | −291 |
| Net profit | 11 | 17 | 6 056 | 5 072 | 4 645 | 1 265 | 31 176 | −10 619 | −2 339 | 4 924 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 32 345 | 31 906 | 31 007 | 35 598 | 34 953 | 31 259 | 64 677 | 64 724 | 62 442 | 64 846 |
| Equity | 11 015 | 5 332 | 11 387 | 16 459 | 20 604 | 18 869 | 47 045 | 34 026 | 31 687 | 36 611 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |
| Short-term debt | 3 000 | 7 948 | 4 245 | 3 740 | 266 | 235 | 502 | 109 | 332 | 623 |
| Total debt | 3 000 | 7 948 | 4 245 | 3 740 | 266 | 235 | 502 | 109 | 332 | 623 |
EBITDA margin
408.6%
This company
15.8%
Market median
+2486% vs market
20162025
Equity ratio
56.5%
This company
38.2%
Market median
+48% vs market
20162025
Return on equity
13.4%
This company
18.4%
Market median
+27% vs market
20162025
Net profit margin
1867.4%
This company
8.1%
Market median
+22954% vs market
20162025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20162025
Debt / equity
0.77×
This company
0.62×
Market median
+24% vs market
20162025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-09-01 – 2020-08-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-09-01 – 2019-08-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-09-01 – 2018-08-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-09-01 – 2017-08-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2015-09-01 – 2016-08-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MV Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
| Audit | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Ehrnebo Development AB 
Pharm Assist Sweden AktiebolagBoard members of Ehrnebo Development AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mats Vilhelm Ehrnebo | Chief Executive Officer | 0 companies |
| Eva Maria Andersson Dverstorp | Audit | 0 companies |
| Monica Sofia Nylund | Deputy Board Member | 0 companies |